ES2553423T3 - Viroterapia oncolítica para el tratamiento del sarcoma de Ewing - Google Patents
Viroterapia oncolítica para el tratamiento del sarcoma de Ewing Download PDFInfo
- Publication number
- ES2553423T3 ES2553423T3 ES12735448.8T ES12735448T ES2553423T3 ES 2553423 T3 ES2553423 T3 ES 2553423T3 ES 12735448 T ES12735448 T ES 12735448T ES 2553423 T3 ES2553423 T3 ES 2553423T3
- Authority
- ES
- Spain
- Prior art keywords
- ewing
- sarcoma
- treatment
- oncolytic virotherapy
- virotherapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/768—Oncolytic viruses not provided for in groups A61K35/761 - A61K35/766
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Sampling And Sample Adjustment (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Parvovirus H1 (H1-PV) para uso en un método para el tratamiento de un sarcoma de Ewing.
Description
10
Claims (1)
-
imagen1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11004884A EP2535055A1 (en) | 2011-06-15 | 2011-06-15 | Oncolytic virotherapy for therapy of bone cancer |
EP11004884 | 2011-06-15 | ||
PCT/EP2012/002539 WO2012171654A1 (en) | 2011-06-15 | 2012-06-15 | Oncolytic virotherapy for the therapy of sarcoma |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2553423T3 true ES2553423T3 (es) | 2015-12-09 |
Family
ID=44910019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES12735448.8T Active ES2553423T3 (es) | 2011-06-15 | 2012-06-15 | Viroterapia oncolítica para el tratamiento del sarcoma de Ewing |
Country Status (8)
Country | Link |
---|---|
US (1) | US9333225B2 (es) |
EP (2) | EP2535055A1 (es) |
JP (1) | JP5793242B2 (es) |
AU (1) | AU2012269386B2 (es) |
CA (1) | CA2832368C (es) |
DK (1) | DK2720702T3 (es) |
ES (1) | ES2553423T3 (es) |
WO (1) | WO2012171654A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK3313987T3 (da) * | 2015-06-23 | 2020-02-03 | Deutsches Krebsforsch | Fremgangsmåde til produktion i stor målestok samt oprensning af parvovirus |
EP3225253A1 (en) * | 2016-04-01 | 2017-10-04 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor |
EP3558266B1 (en) | 2016-12-21 | 2022-03-30 | The Board of Regents of The University of Texas System | Altertoxin ii as a selective inhibitor of ewing family of tumor cells |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030044384A1 (en) * | 1997-10-09 | 2003-03-06 | Pro-Virus, Inc. | Treatment of neoplasms with viruses |
WO2003097835A2 (en) * | 2002-05-16 | 2003-11-27 | Molecular Engines Laboratories | Pharmaceutical compositions for the treatment of cancer |
-
2011
- 2011-06-15 EP EP11004884A patent/EP2535055A1/en not_active Withdrawn
-
2012
- 2012-06-15 EP EP12735448.8A patent/EP2720702B1/en active Active
- 2012-06-15 CA CA2832368A patent/CA2832368C/en active Active
- 2012-06-15 JP JP2014515098A patent/JP5793242B2/ja active Active
- 2012-06-15 AU AU2012269386A patent/AU2012269386B2/en active Active
- 2012-06-15 DK DK12735448.8T patent/DK2720702T3/en active
- 2012-06-15 WO PCT/EP2012/002539 patent/WO2012171654A1/en active Application Filing
- 2012-06-15 ES ES12735448.8T patent/ES2553423T3/es active Active
-
2013
- 2013-12-13 US US14/105,599 patent/US9333225B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
DK2720702T3 (en) | 2015-09-07 |
AU2012269386B2 (en) | 2015-10-15 |
AU2012269386A1 (en) | 2013-08-29 |
CA2832368C (en) | 2017-07-25 |
EP2720702A1 (en) | 2014-04-23 |
WO2012171654A1 (en) | 2012-12-20 |
US20140205573A1 (en) | 2014-07-24 |
EP2535055A1 (en) | 2012-12-19 |
US9333225B2 (en) | 2016-05-10 |
CA2832368A1 (en) | 2012-12-20 |
EP2720702B1 (en) | 2015-06-24 |
JP5793242B2 (ja) | 2015-10-14 |
JP2014518206A (ja) | 2014-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2644844T3 (es) | Mecanismo de soporte | |
ES2643848T3 (es) | Método para cuantificar dosis UV desinfectantes usando indicadores | |
UY34201A (es) | Compuestos de azaindol y métodos para el tratamiento de vih. | |
UY4211Q (es) | Pizarra para marcadores | |
UY34593A (es) | Miméticos sintéticos de apelina para el tratamiento de falla cardiaca | |
UY34503A (es) | ?sal de bromhidrato de pridopidina? | |
UY34792A (es) | ?método de uso de profungicidas de uk-2a para control de la roya de soja?. | |
JP2013531018A5 (es) | ||
UY34419A (es) | Profármaco de adrenomedulina basado en polietilenglicol y el uso del mismo | |
JP2012204203A5 (es) | ||
ES2666397T3 (es) | Activación de CD89 en terapia | |
UY34200A (es) | 3-(fluorovinil)pirazoles y su uso | |
UY35274A (es) | Compuestos y métodos para tratar infecciones bacterianas | |
ES2642085T3 (es) | Procedimientos anaeróbicos de tratamiento de lodos | |
ES2633762T3 (es) | Hipertensión e hiperuricemia | |
ES2553423T3 (es) | Viroterapia oncolítica para el tratamiento del sarcoma de Ewing | |
CR20130532A (es) | Aclidinio para uso en la mejora de la calidad del sueño en pacientes respiratorios | |
ES2611776T3 (es) | Uso de sales de tungsteno (VI) para el tratamiento de la esterilidad femenina en mamíferos no diabéticos | |
ES2664171T3 (es) | Aditivo retardador del fraguado y plastificante para el hormigón | |
ES2565198T3 (es) | Metapneumovirus aviar en oncólisis | |
ES2644995T3 (es) | Módulo de filtro | |
ES2528962T9 (es) | Un procedimiento para secar la colada | |
UY34140A (es) | Mejoras en el riego | |
JP2013073724A5 (es) | ||
ES2536842T3 (es) | Composición farmacéutica para el tratamiento del cáncer |